• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
Classification Nameintervertebral fusion device with bone graft, lumbar
Generic Nameintervertebral fusion device with bone graft, lumbar
Regulation Number888.3080
Zimmer Spine, Inc
7375 bush lake road
minneapolis, MN 55439
PMA NumberP950002
Supplement NumberS012
Date Received09/29/2003
Decision Date10/31/2003
Product Code
MAX[ Registered Establishments with MAX ]
Advisory Committee Orthopedic
Supplement Typereal-time process
Supplement Reason change design/components/specifications/material
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval to add the 9mm x 20mm bak vista interbody fusion device, which is manufactured from 65% peek optima and 35% toho besfight c6-uh carbon fiber, to the approved product line for the bak interbody fusion system. The device will be marketed under the trade name bak vista interbody fusion device and is indicated for use with autogenous bone graft in patients with degenerative disc disease (ddd) at the l2-s1 levels. These ddd patients may also have up to grade i spondylolisthesis or retrolisthesis at the involved level(s). Bak devices are to be implanted via an open anterior or posterior approach. Ddd is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These patients would be skeletally mature and have had six months of non-operative treatment.